KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cineverse (CNVS) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Cineverse (CNVS) over the last 17 years, with Q3 2025 value amounting to -$841000.0.

  • Cineverse's Cash from Investing Activities rose 1338.83% to -$841000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$672000.0, marking a year-over-year increase of 1961.72%. This contributed to the annual value of -$635000.0 for FY2025, which is 1958.57% down from last year.
  • Cineverse's Cash from Investing Activities amounted to -$841000.0 in Q3 2025, which was up 1338.83% from -$16000.0 recorded in Q2 2025.
  • Over the past 5 years, Cineverse's Cash from Investing Activities peaked at $165000.0 during Q4 2024, and registered a low of -$7.3 million during Q1 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$213000.0 (2022), whereas its average is -$905052.6.
  • As far as peak fluctuations go, Cineverse's Cash from Investing Activities crashed by 153380.78% in 2021, and later soared by 40000.0% in 2024.
  • Over the past 5 years, Cineverse's Cash from Investing Activities (Quarter) stood at -$211000.0 in 2021, then rose by 26.54% to -$155000.0 in 2022, then skyrocketed by 121.29% to $33000.0 in 2023, then soared by 400.0% to $165000.0 in 2024, then tumbled by 609.7% to -$841000.0 in 2025.
  • Its Cash from Investing Activities stands at -$841000.0 for Q3 2025, versus -$16000.0 for Q2 2025 and $20000.0 for Q1 2025.